Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Benidipine

A dihydropyridine calcium channel blocker developed in Japan, patented in 1981 and approved in 1991 for high blood pressure: it relaxes blood vessels by blocking calcium entry into their muscle cells. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It blocks no fewer than three types of calcium channel, L, N and T, whereas many calcium channel blockers act mainly on L-type channels; it is also described as protective for the kidneys and heart.

BenidipineGo to the active ingredient →
BenidipineActive ingredientBenidipineCat. No. P-B031-001CAS 105979-17-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.